Calendario - The Latin America Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)

The Latin America Congress on

Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)

Hilton Hotel, Buenos Aires, Argentina, March 11-14, 2010

Calendario

08:45-10:30

Plenary Session 1

EVIDENCE FROM THE LAST CLINICAL TRIALS IN DIABETES

Chair: B.L. Wajchenberg and S. Cavalcanti
What should we learn from the main prospective trials in diabetes?

P. Home
Should we diagnose diabetes by A1C only?

Pro: P. Aschner

Con: R.A. deFronzo
PANEL DISCUSSION

G. Fuente, J. Gross

10:30-10:50

Coffee break

10:50-12:30

Session 2
TREATMENT GOALS IN DIABE TES

Chair: M.A. Tambascia
Near normal HbA1c in T2DM?
Pro: S. Del Prato

Con:
How low is low in blood pressure control in patients with diabetes?

R. Carmena

Session 6

OBESITY: CAUSES AND THERAPEUTIC APPROACHES
Disease or predisposing condition?
New pharmacotherapy: What can we expect?

S. Klein
What kind of exercise?

D. Marrero

Session 10

VASCULAR DAMAGE IN DIABETES AND HYPERTENSION

Chair: P. Home
Vasculature in obesity, diabetes and hypertension

C.E. Mogensen
Endothelium target for therapy
Microcirculation window to glomerulus

L. Raij
Hemorheologic factors in D M
R. Lyra

12:30-13:10

Lunch break

13:10-14:00

Session 3
MEET THE PROFESSOR
Self and continuous monitoring in T2DM patients
Coordinator: J. Davidson

Professor: V. Commendatore

Session 7

MEET THE PROFESSOR
Should physicians measure BMI or waist circumference in clinical practice?
Coordinator: S. Schraier

Professor: S. Klein

Session 11

MEET THE PROFESSOR
The Metabolic Syndrome: Insulin Resistance in Disguise
Coordinator: M. Bendersky

Professor: R.A. DeFronzo

14:10-15:40

Session 4

WHICH IS THE MOST IMPORTANT CARDIOVASCULAR RISK IN DIABETES?
Chair: M. de Sereday
PP hyperglycemia

M. Hanefeld
Lipoprotein disorders

R. Carmena
Focus on blood pressure
Obesity

S. Klein

Session 8

SMOKING CESSATION - GET READY FOR SUCCESS!

Chair: P.M. Nilsson
Evolutionary perspectives on addiction leading to smoking, obesity and drug abuse

P.M. Nilsson
Nicotine dependence - Why, how and when?

K.O. Fagerström
Smoking - The global epidemic

P. Tønnesen
Smoking cessation strategies. The evidence.
Non-pharmacological support and councelling
Drug treatment
The integrated approach to the smoking risk patient
PANEL DISCUSSION

Session 12

CAUSE OF HYPERTENSION
Chair: G. Waisman

Role of autonomic system
A. Ramirez

Role of angiotensin-renin system
PANEL DISCUSSION

15:40-16:00

Coffee break

16:00-17:30

Session 5

DIFFERENT PHENOTYPES OF DIABETES

Chair: G. Frechtel
LADA: combination of type 1 and type 2 diabetes

P. Pozzilli
Type 2 diabetes in the young

I. Libman
Type 1 diabetes plus metabolic syndrome

I. D. Escobar

Session 9

ORAL PRESENTATIONS

Novel Mechanisms for the

Treatment of T2DM

H. Katzeff

Long-acting weekly GLP-1 receptor agonists: How far have we gone?
J. Rosenstock, USA

Session 13

INSULIN THERAPY
Chair: G. Fuente

Diabetes intensive treatments in hospitals
P. Pozzilli
Intensification of Insulin treatment in T2D

J. Gross
Safety of modern insulins

Saturday, March 13, 2010

Hall A

Hall B

Hall C

08:45-10:30

Session 14

T2D-FIRST LINE OF THERAPY?
Combination therapy Vs. Monotherapy
Combination therapy: S. Del Prato
Monotherapy: P. Home

Secretagos; Which one?

M. Vinocour

PANEL DISCUSSION

C. Musso, A. Chacra

Session 19

OBESITY AND METABOLIC SYNDROME
Chair: S. Kahn

Diet, exercise or both?
Diet: D. Marrero
Excercise: M. Rodriguez
Is there light in the future for new pharmalogical agents?

S. Klein
Relationship of insulin resistance weight to structural and functional disorders of the thyroid

J. Garber

Session 23

NEW HORIZONS IN THE TREATMENT OF T2D
Early insulin therapy in type 2 diabetic patients

Pro: A. Chacra

Con: L. Litwak
TZD dead or alive?

Pro: I. Sinay

Con: P. Aschner
PANEL DISCUSSIO N

M. Vinocour

10:30-10:50

Coffee break

10:50-12:30

Session 15

GLP-1 RECEPTOR AGONISTS AND DPP-4 INHIBITORS. A CLINICAL COMPARISON
Glycaemic control
S. Kahn

Impact on non glycaemic effect
Potential to reduce CV risk

R.D. Santos
PANEL DISCUSSION

Session 20

LIPIDS IN DIABETES

Chair: C. Rondinone
Metabolic consequences of lipotoxicity in obesity: Prevention and treatment

K. Cusi
Intramyocellular / liver lipid / myo cardial fat
Prevention of T2DM: To treat or not to treat?

Treat: A. Halpern
Not treat: K. Cusi

Session 24

NOVEL TREATMENTS IN DIABETIC PATIENTS WITH HYPERTENSION
Chair: M. Vinocour

Antihypertensive treatment in “normotensive diabetic patient”
Pro: M. Bendersky

Con: C.E. Mogensen
The positive side of future treatments

12:30-13:10

Lunch break

13:10-14:00

Session 16

MEET THE PROFESSOR
Post meal glucose variability: Does it make a difference in prediabetes or diabetes?
Coordinator: M. Escalante

Professor:

Session 21

MEET THE PROFESSOR
Nonalcoholic fatty liver disease (NAFLO): Fact or fiction?
Coordinator: K. Cusi
Professor:

Session 25

MEET THE PROFESSOR
The use of diurectics in the treatments of blood pressure in patients with T2D
Pro: P.M. Nilsson

Con: L. Raij

14:10-15:40

Session 17
TREATMENT TARGET: SHOULD WE TARGET ON BETA CELL ONLY?

Chair: J. Mestman
Beta cell: J.J. Gagliardino
Alpha cell, muscle, liver and episode tissue: R.A. DeFronzo

Session 22

TREATMENTS OF T2D

Chair: S. Gutt
Bariatric surgery as a treatment for diabetes and obesity
Pro: A. Halpern
Con: S. Klein
PANEL DISCUSSION

S. Schraier

Session 26

DIABETIC NEPHROPATHY BEYOND RAS INHIBITOR
Chair: J. Garber

Calcium channel blockers/ diuretics

L. Raij
Double or triple RAS blocked
Blockade of inflammatory pathways
J.F. Navarro-Gonzalez

PANEL DISCUSSION

R. Lyra

15:40-16:00

Coffee break

16:00-17:30

Plenary Session 18
DIABETIC FOOT: INTERDISCIPLINARY INTERVENTION

H.C. Pedrosa

Vascular surgeon

A.C. de Souza
Interventional radiologist
Orthopedic intervention

Sunday, March 14, 2010

Hall A

08:45-10:30

Session 27

HAPO STUDY

Chair: Z. Shoham
Results of the Hyperglycemia & Adverse Pregnancy Outcome (HAPO) Study: Implications for Clinical Practice

B. Metzger
Insulin

C. Faingold
Non-Insulin intervention
Maternal hyperglycaemia: Long term effect on offspring

J. Mestman
PANEL DISCUSSION

J. Mestman

10:30-10:50

Coffee break

10:50-12:30

Plenary Session 29

NEUROPATHY GUIDELINES

13:10-14:00

Closing